Dr. O’Reilly on Immunotherapy in Pancreatic Cancer – OncLive
The Japan News |
Dr. O'Reilly on Immunotherapy in Pancreatic Cancer
OncLive Eileen O'Reilly, MD, associate director for clinical research at Memorial Sloan Kettering Cancer Center, discusses the role of immunotherapy in patients with pancreatic cancer. According to O'Reilly, there is compelling science and biology behind using … Asia Pacific Cancer Immunotherapy Market – Doubling the market in just 4.6 years! The explosive power of ~15.5 … MRFR Released Cancer Immunotherapy Market Trends, Share, Size, Growth, Opportunities and Forecasts Till 2023 Transforming cancer treatment with Immunotherapy (TechVision) |
